Navamedic ASA N1A.F Stock
Navamedic ASA Price Chart
Navamedic ASA N1A.F Financial and Trading Overview
Navamedic ASA stock price | 2.91 EUR |
Previous Close | 3.27 EUR |
Open | 3.32 EUR |
Bid | 3.3 EUR x 0 |
Ask | 3.37 EUR x 0 |
Day's Range | 3.32 - 3.32 EUR |
52 Week Range | 2.37 - 3.81 EUR |
Volume | 500 EUR |
Avg. Volume | 11 EUR |
Market Cap | 58.4M EUR |
Beta (5Y Monthly) | 0.437547 |
PE Ratio (TTM) | 22.133331 |
EPS (TTM) | 0.02 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
N1A.F Valuation Measures
Enterprise Value | 59.23M EUR |
Trailing P/E | 22.133331 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.13245936 |
Price/Book (mrq) | 0.25376442 |
Enterprise Value/Revenue | 0.134 |
Enterprise Value/EBITDA | 0.899 |
Trading Information
Navamedic ASA Stock Price History
Beta (5Y Monthly) | 0.437547 |
52-Week Change | 31.72% |
S&P500 52-Week Change | 20.43% |
52 Week High | 3.81 EUR |
52 Week Low | 2.37 EUR |
50-Day Moving Average | 3.26 EUR |
200-Day Moving Average | 3.22 EUR |
N1A.F Share Statistics
Avg. Volume (3 month) | 11 EUR |
Avg. Daily Volume (10-Days) | 50 EUR |
Shares Outstanding | 17.23M |
Float | 10.22M |
Short Ratio | N/A |
% Held by Insiders | 41.56% |
% Held by Institutions | 21.67% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 9.83% |
Operating Margin (ttm) | 13.76% |
Gross Margin | 42.86% |
EBITDA Margin | 14.93% |
Management Effectiveness
Return on Assets (ttm) | 10.98% |
Return on Equity (ttm) | 22.97% |
Income Statement
Revenue (ttm) | 440.93M EUR |
Revenue Per Share (ttm) | 25.59 EUR |
Quarterly Revenue Growth (yoy) | 93.30% |
Gross Profit (ttm) | 163.52M EUR |
EBITDA | 65.86M EUR |
Net Income Avi to Common (ttm) | 43.35M EUR |
Diluted EPS (ttm) | 0.15 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 56.73M EUR |
Total Cash Per Share (mrq) | 3.29 EUR |
Total Debt (mrq) | 59.46M EUR |
Total Debt/Equity (mrq) | 26.38 EUR |
Current Ratio (mrq) | 2.046 |
Book Value Per Share (mrq) | 13.083 |
Cash Flow Statement
Operating Cash Flow (ttm) | 39.53M EUR |
Levered Free Cash Flow (ttm) | 26.13M EUR |
Profile of Navamedic ASA
Country | Germany |
State | N/A |
City | Oslo |
Address | Henrik Ibsensgate 100 |
ZIP | 0255 |
Phone | 47 67 11 25 40 |
Website | https://www.navamedic.com |
Industry | Medical Distribution |
Sector(s) | Healthcare |
Full Time Employees | 35 |
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Q&A For Navamedic ASA Stock
What is a current N1A.F stock price?
Navamedic ASA N1A.F stock price today per share is 2.91 EUR.
How to purchase Navamedic ASA stock?
You can buy N1A.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Navamedic ASA?
The stock symbol or ticker of Navamedic ASA is N1A.F.
Which industry does the Navamedic ASA company belong to?
The Navamedic ASA industry is Medical Distribution.
How many shares does Navamedic ASA have in circulation?
The max supply of Navamedic ASA shares is 17.77M.
What is Navamedic ASA Price to Earnings Ratio (PE Ratio)?
Navamedic ASA PE Ratio is 145.50000000 now.
What was Navamedic ASA earnings per share over the trailing 12 months (TTM)?
Navamedic ASA EPS is 0.02 EUR over the trailing 12 months.
Which sector does the Navamedic ASA company belong to?
The Navamedic ASA sector is Healthcare.